Diabetes and Breast Cancer: An Analysis of Signaling Pathways

Diabetes and Breast Cancer: An Analysis of Signaling Pathways is an in-depth monograph that explores the cross-talk between diabetes and breast cancer. The edited volume sheds light on the complex relationship between the two diseases by explaining the critical regulatory signaling in their progression. Topics covered in the book include the genetic similarities between type 2 diabetes and breast cancer, signaling pathways for breast cancer cell invasion and migration (including fat cadherin, Wnt signaling and IGF signaling).and research on associated conditions such as neuropathy, inflammation, hypoxia and obesity. A summary of new natural medicines for targeting these diseases is also included. Scholars, academicians, and professionals in medicine and pharmaceutical research who want to gain a better understanding of the complex interplay between diabetes and breast cancer will learn about the underlying biochemical mechanisms, pharmacogenomics, and precision medicine approaches for the simultaneous management of both diseases Key Features - Gives a comprehensive overview of the cross-talk between diabetes and breast cancer - Covers information on multiple signaling pathways and associated conditions - Provides insights contributed by biomedical experts with detailed references Readership Research scholars, academicians, healthcare professionals (endocrinologists, oncologists, internal medicine specialists) and R&D professionals in pharmaceutical chemistry.Diabetes and Breast Cancer: An Analysis of Signaling Pathways is an in-depth monograph that explores the cross-talk between diabetes and breast cancer. The edited volume sheds light on the complex relationship between the two diseases by explaining the critical regulatory signaling in their progression. Topics covered in the book include the genetic similarities between type 2 diabetes and breast cancer, signaling pathways for breast cancer cell invasion and migration (including fat cadherin, Wnt signaling and IGF signaling).and research on associated conditions such as neuropathy, inflammation, hypoxia and obesity. A summary of new natural medicines for targeting these diseases is also included. Scholars, academicians, and professionals in medicine and pharmaceutical research who want to gain a better understanding of the complex interplay between diabetes and breast cancer will learn about the underlying biochemical mechanisms, pharmacogenomics, and precision medicine approaches for the simultaneous management of both diseases Key Features - Gives a comprehensive overview of the cross-talk between diabetes and breast cancer - Covers information on multiple signaling pathways and associated conditions - Provides insights contributed by biomedical experts with detailed references Readership Research scholars, academicians, healthcare professionals (endocrinologists, oncologists, internal medicine specialists) and R&D professionals in pharmaceutical chemistry.